Clinical trials
Completed trials in Cambodia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 8 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 9 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 96 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Oxford | 14 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 9 |
| University of British Columbia | 7 |
| ANRS, Emerging Infectious Diseases | 5 |
| Institute of Tropical Medicine, Belgium | 4 |
| Medicines for Malaria Venture | 3 |
| National University of Singapore | 3 |
| University Ghent | 3 |
| Armed Forces Research Institute of Medical Sciences, Thailand | 2 |
| Foundation for Innovative New Diagnostics, Switzerland | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria, Falciparum | 16 |
| Malaria | 13 |
| Tuberculosis | 7 |
| Malaria, Vivax | 5 |
| Dengue | 4 |
| HIV Infections | 4 |
| Acquired Immunodeficiency Syndrome | 3 |
| Anemia | 3 |
| Disease | 3 |
| Fever | 3 |
Trials
Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.